Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Skin warning study for allergic reactions to traditional Chinese medicine injections
ChiCTR-CPC-15006921Phase 4Recruiting
- Sponsor
- Second Affiliated Hospital of Tianjin University of Traditional Chinese Medicine
- Start
- May 2015
- Modality
- Small Molecules, Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules, Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label trial of salvia miltiorrhiza polyphenolic acid, ginkgo lactone and Ginkgo diterpene lactone meglumine in drug allergy (3 arms), sponsored by Second Affiliated Hospital of Tianjin University of Traditional Chinese Medicine. Primary endpoint: Allergic reaction rate and composition of positive skin test reactions after salvia miltiorrhiza polyphenolic acid testing. Started May 2015; status: recruiting.
02
Drugs
salvia miltiorrhiza polyphenolic acidginkgo lactoneGinkgo diterpene lactone meglumine
03
Conditions
drug allergy
Beyond the preview
Go deeper on ChiCTR-CPC-15006921.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR-CPC-15006921.